Singapore’s Agency for Science, Technology and Research (A*STAR) and Australia’s National Health and Medical Research Council (NHMRC) have signed a Memorandum of Understanding (MOU) to promote exchange between the two countries in the areas of health and medical research.

 

Under the MOU, A*STAR and NHMRC will commit a total of SGD$4.5m (AUD$3.5m) to a joint grant call over the next three years.  The grant will fund collaborative research projects between groups in Singapore and Australia, in areas such as emerging infectious diseases, regenerative medicine, non-communicable diseases, bioinformatics and nanotechnology. 

 

A*STAR and NHMRC will co-organise scientific symposia to help establish research collaborations across Singapore and Australia.  The symposia will provide a platform for researchers from both countries to share their latest research and to network with each other.  The first symposium is scheduled to take place in Australia in 2012.

 

Professor Warwick Anderson, CEO of Australia’s National Health and Medical Research Council said, “Formalising this agreement with A*STAR will open up new opportunities for Australian and Singaporean researchers to work together to tackle some of the significant health issue in our region.  Through these international collaborations we will be better placed to bring together the best international research to fight health challenges today and into the future.”

 

In addition, under the MOU, A*STAR and NHMRC will facilitate research exchanges for postdoctoral fellows between institutes in Singapore and Australia.  This will allow the exchange of scientific data, as well as provide scientists with exposure and training in new research techniques.

 

Singapore’s past engagements with Australian scientific institutions include an MOU with the Australian Department of Innovation, Industry, Science and Research (DIISR) in 2009, and two symposia co-organised with the Australian Academy of Sciences (AAS), in Energy and Stem Cells. 

 

The MOU with DIISR has produced collaborations involving researchers from multiple Singapore institutes, including A*STAR’s Institute of Molecular and Cell Biology (IMCB) and Singapore Bioimaging Consortium (SBIC), Duke-NUS Graduate Medical School, and National Heart Centre Singapore.